KANMN NMN 30,000mg
KANMN delivers a pharmaceutical-grade dose of Nicotinamide Mononucleotide (NMN), a direct precursor to NAD+ — a coenzyme essential for cellular energy metabolism, DNA repair, and sirtuin activation.
Key Health Benefits
- ✓Raises NAD+ levels in blood and tissues, which decline by up to 50% between ages 40 and 60
- ✓Activates sirtuins (SIRT1–SIRT7), proteins linked to longevity, metabolic regulation, and inflammation control
- ✓Supports mitochondrial biogenesis and ATP production for sustained energy
- ✓Promotes DNA repair mechanisms, reducing oxidative damage accumulation
- ✓May improve insulin sensitivity and metabolic markers in aging adults
Clinical Research
A landmark 2021 human clinical trial published in Science (Yoshino et al.) demonstrated that oral NMN supplementation safely raises NAD+ metabolites in skeletal muscle and improves insulin signaling in postmenopausal women. Preclinical studies in Nature Metabolism (Mills et al., 2016) showed NMN reversed age-associated physiological decline in mice. Ongoing Phase II trials at Washington University School of Medicine continue to validate NMN's safety and efficacy profile.